EVGN
Evogene Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$0.54
−1.30%Leverage
- Debt / equity
- -0.64x
- Net debt / equity
- 2.20x
- Debt / assets
- 0.16x
- Debt / EBITDA
- -0.17x
- Net debt / EBITDA
- 0.58x
Liquidity & coverage
- Current ratio
- 3.57x
- Quick ratio
- 3.54x
- Cash ratio
- 3.07x
- Interest coverage
- -2.79x
- EBITDA / interest
- -2.59x
- Working capital
- $7.8M
Cash & dividend
- FCF / debt
- -5.50x
- Cash flow / debt
- -5.49x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026